Research Article on COVID-19 mRNA vaccination and anaphylaxis

There has been significant concern in the rare disease community following reports of severe allergic reactions to the COVID-19 mRNA vaccines. This article breaks down the 4 pathways which are believed to cause these reactions, examines the literature for those most at risk, and provides a risk-benefit analysis of vaccination in the case of anaphylaxis.

To Vaccinate or not to Vaccinate_v6.pdf

Download PDF • 172KB